U nder current guidelines, a running, slowly absorbable suture is recommended for the closure of the abdominal wall after laparotomy.
1 However, this technique is associated with a considerable incidence of incisional hernia. Despite a wide variability of reported incidence, relevant studies [2] [3] [4] [5] indicate a frequency between 10% and 30% on longterm follow-up. Novel techniques, including the use of small bites, may reduce the incidence of incisional hernia after midline laparotomies. 6, 7 However, despite technical modifications, the rate of incisional hernia remains clinically significant, with an incidence of up to 13% 6, 7 ; therefore, it is important to reduce incisional hernia in patients undergoing open abdominal surgery.
The benefit of prophylactic mesh implantation in reducing the incidence of incisional hernia after laparotomy has been reported in previous studies. [8] [9] [10] Onlay or sublay mesh position was investigated in most studies, [10] [11] [12] [13] which requires additional dissection of the abdominal wall, is time consuming and can therefore be a hindrance in routine prophylactic mesh implantation. Furthermore, an elevated rate of seroma formation was reported after onlay and sublay mesh implantation, potentially because of the increased wound surface area. 8, 14 Intraperitoneal placement of modern dual-layered meshes could potentially overcome these limitations by reducing the time required for mesh implantation and minimizing dissection of the abdominal wall. 15, 16 Therefore, the efficacy of prophylactic intraperitoneal mesh implantation for the prevention of incisional hernia after laparotomy was tested in a randomized clinical trial.
To maximize the benefit-risk ratio, prophylactic mesh implantation would ideally be performed in patients at elevated risk for hernia development. Previous studies 17, 18 explored the outcome of prophylactic mesh implantation after specific procedures with elevated risk for incisional hernia, such as bariatric or abdominal vascular surgery. The current study explores a population undergoing general abdominal surgery, including hepatobiliary, pancreatic, and upper and lower gastrointestinal tract surgery. A population at risk was defined by patient-related risk factors that can be recognized preoperatively. Such stratification allows identification of patients at elevated risk for incisional hernia development, who potentially benefit the most from mesh implantation. Numerous preoperative recognizable risk factors for incisional hernia have been described in the literature, including overweight or obesity, low hemoglobin level, uremia, male sex, old age, smoking, previous laparotomy, and diagnosis of neoplastic disease. [2] [3] [4] [19] [20] [21] [22] [23] [24] [25] To ensure practicability in daily clinical routine, only strong risk factors were included for stratification that are dichotomous, occur frequently, and are easy to identify. Thus, the following risk factors were used for patient stratification: overweight or obesity, diagnosis of neoplastic disease, male sex, and history of laparotomy. Patients with at least 2 of these risk factors were included. With this study design, we tested the hypothesis that primary mesh implantation in an intraperitoneal position reduces the risk of incisional hernia in a population at risk.
Methods

Trial Design
An open-label randomized clinical trial with 1:1 randomization in 2 parallel groups was performed at the Department of Visceral Surgery and Medicine in the University Hospital of Bern, Bern, Switzerland. The trial protocol can be found in Supplement 1. The study was conducted under the working title ProphMesh. The study, including the increase of sample size, was approved by the Ethical Committee of the Canton of Bern.
Participants
Patients seen at the visceral surgical outpatient department who were scheduled for open abdominal surgery from January 1, 2011, to February 29, 2014, were assessed for eligibility. Inclusion criteria were age older than 18 years, elective operation, and the presence of at least 2 of the following risk factors for incisional hernia development: body mass index above 25 (calculated as weight in kilograms divided by height in meters squared), diagnosis of neoplastic disease, male sex, and history of laparotomy. Exclusion criteria were previous intraperitoneal mesh placement, previous incisional hernia, emergency procedures, and patients with inflammatory bowel disease. All patients had to sign informed consent forms before inclusion in the study. Data were deidentified with a key according to Swiss regulations. Data were analyzed in August 2017.
Interventions
The scheduled operation was performed as planned. In the control group, the abdominal wall was closed according to the institutional standard operating procedure, using a slowly absorbable running suture (USP 1 PDS II loop, Ethicon, Johnson & Johnson). The distance of the stitches to the fascial border was 1 cm, and the distance between stitches was also 1 cm. In the intervention group, a mesh was implanted before closure of the abdominal wall in a standardized fashion. A doublelayered polypropylene-polyvinylidene fluoride mesh (Dynamesh-IPOM, FEG Textiltechnik) was tailored to overlap lateral and cranial-caudal borders by at least 5 cm. Meaning Incisional hernia is a frequent complication after open abdominal surgery; intraperitoneal mesh implantation is a simple and effective measure to prevent this complication.
Prolene; Ethicon) in all 4 corners. After the initial fixation, the borders of the mesh were fixed to the abdominal wall circumferentially using running polypropylene suture to prevent any intestinal structures to herniate onto the mesh. Afterward, the abdominal wall was closed as described in the control group. In both groups, the subcutaneous tissue was not adapted separately; the skin was closed using interrupted stitches with polypropylene sutures (USP 3-0 Prolene; Ethicon) or skin staples, according to the surgeon's choice.
Outcomes
Data collection was performed at the outpatient department preoperatively and at 6 weeks, 1 year, and 3 years postoperatively. Patients were interviewed according to the respective questionnaires, and a clinical examination was performed by observers not otherwise involved in the planning or conduct of the study. The primary outcome of the study was the incidence of an incisional hernia as defined by the European Hernia Society: an abdominal wall gap with or without bulge in the area of the postoperative scar palpable by clinical examination. 26 The patients were seen for follow-up visits at the outpatient department and examined by a qualified physician with at least 2 years of surgical training. Imaging studies were performed if there was uncertainty about the diagnosis. Mean follow-up time was 16.9 months in the control group and 18.7 months in the intervention group. Secondary outcomes were the occurrence of postoperative complications; hematoma, intestinal paralysis, and inhospital mortality were reported until 30 days postoperatively. Fistula formation, small-bowel obstruction, and surgical site infection (SSI) were reported for the whole follow-up period of 3 years. 27 Pain levels were assessed during the hospital stay and at 6 weeks, 1 year, and 3 years postoperatively. During follow-up consultations, patients were asked whether they still felt pain in the abdominal region and to rate the intensity of pain on a visual analog scale (VAS) from 0 to 10, with 0 indicating no pain and 10 indicating worst imaginable pain. Furthermore, they were asked to report whether they perceived pain at least once a day. Range of motion for trunk flexion and extension was assessed before and after surgery by measuring finger-to-floor distance and umbilicus-xiphoid distance in upright position and in maximal trunk retroflection.
Sample Size
On the basis of existing studies, 2,4,28 we expected 25% of control patients from our at-risk population to develop an incisional hernia during the 3 years. In patients with an implanted mesh, an incidence of approximately 5% was expected, as observed in patients undergoing similar operations in our department before the initiation of the study. 29 We calculated that a total of 150 patients needed to be included in the study to demonstrate the difference, presuming a 2-sided level of significance at 5% and a power of 80%. This number also allowed for a loss to follow-up of up to 20% in the patient sample. Because of the unexpectedly high number of patients (n = 19) excluded from the study during surgery, the aimed sample size was increased from 150 to 170 to ensure that 150 patients were treated according to randomization. An amendment was written and approved by the local ethics committee on February 12, 2013.
Randomization
Randomization was performed in permuted blocks of 30 patients, using the online tool randomization.com by an external study nurse. Sealed and numbered envelopes that contained the allocated group were prepared and opened during surgery before abdominal wall closure.
Statistical Analysis
Continuous variables were described using means (SDs). For categorical values, numbers (percentages) were calculated. Differences between groups were compared using the 2-tailed, unpaired t test or Mann-Whitney test for continuous variables and the Fisher exact test for categorical variables. Statistical significance was defined as 2-sided P < .05. In this intent-to-treat analysis, patients randomized to the mesh group were analyzed in the mesh group even if the mesh was explanted during follow-up. Patients in the control group were analyzed in the control group even if they underwent additional surgery with eventual prophylactic mesh implantation. Analysis was performed using SPSS statistical software, version 21 (IBM Corp) and Prism software, version 6 (GraphPad). A Kaplan-Meier curve of the occurrence of incisional hernias stratified by treatment group was plotted, and a log-rank test was used to compare the hernia incidence between the groups.
Results
Demographics
A total of 169 patients were randomized into a control group (n = 86) or a mesh group (n = 83). Nineteen patients were excluded from the study during surgery because new information that conflicted with the inclusion or exclusion criteria became evident (existing incisional hernia, finding of an implanted mesh), second-look surgery became necessary, or surgery revealed a terminal stage of disease (peritoneal carcinomatosis) with the surgeon disagreeing with mesh implantation. Therefore, 81 patients in the control group and 69 in the mesh group were studied (mean [SD] Figure 1 . Baseline data were similar between groups (Table 1).
Primary Outcome
The incidence of incisional hernia 3 years after surgery was significantly higher in the control group vs the mesh group (15 of 81 [18.5%] vs 5 of 69 [7.2%] ). Comparison of the cumulative hazard curves revealed a statistically significant difference between the groups (log-rank test P = .03) (Figure 2) . In both groups, most hernias occurred during the first year after surgery. Follow-up at 1 year resulted in incisional hernia in 13 of 51 individuals (25.5%) in the control group vs 3 of 45 individuals (6.7%) in the mesh group. At the 3-year follow-up visit, 7 of the 30 control group patients (23.3%) presented with a hernia compared with 3 of 30 mesh group patients (10.0%).
Reasons for hernia occurrence in the mesh group were mesh removal in one patient and an additional laparotomy with abdominal wall closure using resorbable suture material in another patient. For the other patients with hernia occurence in the intervention group, the reason for failure of the implanted mesh remains unclear.
Secondary Outcomes
There was no statistically significant difference between the control and intervention groups concerning occurrence of hematoma (1.2% vs 1.4%; P > .99), intestinal paralysis (4.9% vs 4.4%; P > .99), length of hospital stay (13.5 vs 13 days; P = .46), or in-hospital mortality (3.7% vs 1.4%; P =. 62)( Table 2 ). The incidence of small-bowel obstruction was similar between the groups during the entire observation time (Table 2) . No enterocutaneous fistula was observed in either group during follow-up. The incidence of SSI was not statistically different be- 
Control group
The curves are significantly different (P = .03, log-rank test).
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Effectiveness of Prophylactic Intraperitoneal Mesh Implantation for Prevention of Incisional Hernia compared with 5 [1-9] weeks; P = .03). Surgical wound revisions were more frequent in the mesh group (Table 2) . Pain was similar between the groups during hospital stay ( Table 3) . At 6 weeks, significantly more patients in the mesh group reported postoperative pain compared with patients in the control group (34 of 52 [65.4%] vs 26 of 59 [44.1%]; effect size, 21.3%; 95% CI, 4%-41%; P = .04). Pain intensity was higher in the mesh group compared with the control group at 6 weeks (mean VAS score, 1.61 vs 0.83; VAS score difference, 0.78; 95% CI, 0.10-1.46; P = .02). At 1 and 3 years after surgery, no difference in pain perception was observed between the groups (Table 3) .
Trunk extension, assessed by elongation of umbilicusxiphoid distance, was significantly reduced in the mesh group compared with the control group at 12 months (2.40 vs 1.73 cm; effect size, 0.675; 95% CI, 0.18-1.1; P = .009) but not at 36 months after surgery. Trunk flexion, as assessed by finger-to-floor distance, was not significantly different between the groups at all follow-up time points (eFigure in Supplement 2).
Discussion
Our findings reveal that prophylactic intraperitoneal mesh implantation significantly reduces the incidence of incisional hernia 3 years after laparotomy compared with standard abdominal closure in a high-risk population. This study confirms previous reports [8] [9] [10] 29 that found similar effects of prophylactic mesh implantation. The current study has 2 main differences to most previous reports. 8, 9 First, the study population represents patients with elevated risk profile for hernia development that are patient and not procedure related. Second, a double-layered mesh was implanted in an intraperitoneal position, whereas previous studies 10-12 explored mesh implantation in onlay or sublay positions. The incidence of incisional hernia in the control group was above average for an elective surgical population but in the same range as reported in current studies [9] [10] [11] [12] on prophylactic mesh implantation in at-risk patient collectives. This finding indicates that the simple scoring system used allows identification of a population at elevated risk for hernia development based on personal risk factors that can be recognized preoperatively. The incidence of incisional hernia was significantly lower in the mesh group, showing that intraperitoneal mesh implantation is effective for prevention of hernia development. Among the 5 hernias that developed in the mesh group, 2 occurred because of technical aspects during secondary surgery, including mesh removal and mesh adaptation using resorbable suture material.
In our study, the calculated number needed to treat is 8.9; accordingly, 9 patients have to undergo prophylactic mesh implantation to prevent 1 incisional hernia. This number is in line with the current literature that shows a number needed to treat between 5 and 10 for prophylactic mesh implantation in patients undergoing surgical procedures with an increased risk of hernia formation. 8 Because not every incisional hernia needs surgical repair, the number needed to treat to prevent 1 hernia repair is likely to be higher. We believe that risk assessment for incisional hernia should be performed to keep the number needed to treat low and to reduce unnecessary mesh implantations.
The recently published results of the Small Bites Versus Large Bites for Closure of Abdominal Midline Incisions (STITCH) trial revealed a decrease of incisional hernias after 1 year of follow-up with a small-bite technique. 6 Because of the focus on a high-risk population in the current study, a direct comparison of hernia rates is not accurate. Prophylactic mesh implantation vs the small-bite technique should be compared directly in a future study. Implantation of a mesh in an intraperitoneal position was not associated with an increase in the incidence of SSI. However, patients who developed SSI experienced delayed wound healing (Table 2) . Such delayed wound healing is most likely the consequence of secondary infection of the prosthesis. The median healing time in the mesh group was 2 months; 5 of 12 patients had a chronic wound, defined as a healing time of more than 3 months. 30 The fact that more than half of patients with mesh infection healed without mesh removal may be because the mesh was based on polypropylene and not on polyester that is more prone to chronic infection. 31-33 Small-bowel obstruction, which potentially may occur after mesh implantation, was not significantly different between the 2 groups at long-term follow-up. No fistula was detected in either group, which is in line with the literature.
34-36
Chronic postoperative pain is a potential challenge in hernia surgery and after prophylactic mesh placement. Prevalence and intensity of pain 6 weeks postoperatively were significantly higher in the mesh group compared with the control group. This elevated pain might be caused by tension through mesh fixation sutures in the abdominal wall or by inflammatory reaction to the implanted mesh. However, there was no difference in pain at long-term follow-up.
A preventive measure should be simple and fast in its application, which is where we see the advantage of the intraperitoneal onlay mesh technique. The mesh can be implanted without creating an additional wound surface area because no further dissection of the abdominal wall is needed. In the present study, clinically relevant long-term meshassociated complications, such as erosion and formation of adhesions, were not observed.
Limitations
Limitations of the study include the high rate of unavailability for follow-up, the exclusion of patients during surgery, and lack of quality-of-life assessment. Because this study investigated a high-risk population with a significant fraction of patients with malignant disease, mortality was observed in some patients before reaching the end point. In the power calculation, a loss to follow-up of 20% was initially calculated. Therefore, the actual loss of patients was underestimated, mainly because of mortality and withdrawal from study participation. However, there was no difference in loss to follow-up between the 2 groups. Mesh implantation needed to be documented in the operation report to inform medical personnel responsible for aftercare and to ensure patient safety. Therefore, masking of the patient and the assessor during follow-up visits was not possible. To minimize bias, the assessor was a person not involved in the study and patient care. The elevated exclusion of patients randomized to receive mesh implantation may represent a reluctance of surgeons to implant a mesh prophylactically, especially in patients excluded because of a terminal stage of disease. This approach represents another limitation of this study. However, post hoc analysis revealed no major different baseline characteristics in patients intraoperatively excluded. Such reluctance to implant a mesh highlights the need for a better definition of patients who benefit from mesh implantation.
Conclusions
Prophylactic intraperitoneal mesh implantation in patients at risk for incisional hernia is feasible and effective to prevent hernia formation. Adverse effects of mesh implantation include delayed wound healing of SSI, early postoperative pain, and reduced trunk extension.
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In the general surgical patient the current standard is the closure of the abdominal wall using a running, slowly absorbable suture. With this well established clinical practice the incidence remains high and incisional hernia repair must be performed frequently in order to treat patients' symptoms and to prevent progression of the hernia and possible complications. Consequently, in high risk patients prophylactic mesh implantation is performed routinely in our institution.
Aim
To compare prophylactic mesh implantation to conventional abdominal closure in a high-risk population. Risk analysis:
Complications associated with mesh implantation such as lesions to intraabdominal organs or intestinal fistula are extremely rare. Additionally discomfort and decreased mobility for trunk rotation after implantation of large mesh have been rarely reported.
Potential of the study: Incisional hernia after laparotomy is a frequent clinical problem, which is associated with significant morbidity and cost. This study may reveal that prophylactic mesh implantation reduces hernia recurrence in a highly selected group of patients. This effect is potentially associated with no additional costs. 
Background and Aim
Incisional hernia is one of the most common complication in general abdominal surgery. An overall incidence of 20% has been found in retrospective studies, ranging up to 50% in patients with selected risk factors such as obesity [1, 2] . Incisional hernias are associated with a high morbidity such as intestinal incarceration, chronic discomfort and pain of the patient [3] .
The gold standard for the closure of the abdominal wall is a running slowly absorbable suture [4, 5] . Despite this well established clinical practice a high incidence of incisional hernia is observed with up to 26% [6] in selected patients and repair must be performed frequently in order to treat patients symptoms and to prevent progression of the hernia [3] . Prophylactic mesh implantation has been shown to be safe in patients undergoing bariatric surgery [7, 8] . However, the prefascial site of mesh placement in this study was associated with additional surgical site infections.
Modern dual layered meshes were introduced more than 10 years ago [9] . These meshes were successfully used for laparoscopic repair of incisional hernia and are associated with significant reduction of surgical site infection compared to conventional incisional hernia repair [10] [11] [12] .
Since 2005 we implanted intra-abdominal dual-layered meshes in order to prevent incisional hernia in high-risk patients. A total of 52 high-risk patients received a mesh. No additional morbidity such as small bowel obstruction, intestinal fistula or lesions of intra-abdominal organs was observed. After a median clinical follow-up of 18 months we observed postoperative incisional hernia in 2 (4%) of these patients which is significantly lower to the other series [1, 2]. We perform this technique routinely in this subset of patients in our department.
With these encouraging results prophylactic mesh implantation is now performed in all patients with a specific risk profile as detailed below. This approach however, may be more expensive at the initial operation compared to standard abdominal closure without mesh implantation. However, given the relevant costs for reoperations that are between 6 to 20 times higher than the implantation of a prophylactic mesh it seems probable that prophylactic mesh implantation is cost-effective. In particular the costs for incisional hernia repair in our institution range from 11,481 ± 4,806 CHF for laparoscopic repair to 14,680 ± 12,032 CHF for open repair [11] . Cost-effectiveness will be assessed as a secondary outcome parameter.
With this study we want to prospectively compare the outcomes and costs between implantation of a prophylactic mesh and suture only. The main endpoints of the study are incidence of incisional hernia and cost.
Hypothesis and Endpoints
Hypothesis:
Prophylactic implantation of an intra-peritoneal mesh in a high risk population reduces the incidence of incisional hernia.
This hypothesis is based on studies, showing the safety of intra-abdominal mesh implantation [13] . The study will focus on a high-risk population, who is most likely to benefit from the procedure.
Endpoints:
Primary endpoint: incidence of incisional hernia The overall incidence of incisional hernia has been assessed only in retrospective series. In large series an incidence of 19 -26 per cent [6] has been found in general surgical patients. Prospective assessment of incidence of incisional hernia exists only for specific cohorts of patients such as patients undergoing orthotopic liver transplantation or bariatric surgery.
Multivariate analysis of retrospective data have shown that the following preoperatively known factors are independent risk factors for incisional hernia: male gender, body mass index larger than 25kg/m2, malignancy, previous abdominal incision [1, 6, 14] .
In order to analyze a population with a high risk for incisional hernia formation, we will include patients with at least two of the above-mentioned risk factors.
Sample size calculation: With the selection of high risk patients for incisional hernia we expect an incidence of incisional hernia of 25% 3 years post operation [6] . With implanted mesh we expect to lower the incidence of incisional hernia to 5% as observed in our cohort. For the sample size calculation we estimate the level of significance at 5% and a power of 80%. It is estimated that the accrual of patients is constant and that we lose 20% at follow-up. Correction for alpha spending (O'Brian-Flemming) was attributed. Therefore, we need a total of 150 patients to be included into the study. 
Control group
The main operation will be performed as planned. For the closure of the abdominal wall, a standard technique will be applied using a running suture of PDS 1 loop. The distance of the sutures to the fascial border is 1cm and the distance between two stitches is not more than 1cm. The total length of suture is at least 4 times the total length of the abdominal incision.
Treatment group
The main operation will be performed as planned. Prior to the closure of the abdominal wall a mesh will be implanted in a standardized fashion: A Dynamesh IPOM mesh will be used for the present study. The mesh has a width of 15cm and is tailored to overlap lateral and cranial boarders at least 5cm. The mesh will be placed intra-abdominally and fixed using intraabdominal stitches using Prolene 2/0 in all four corners. After the initial fixation of the mesh in all quadrants, the boarders of the mesh will be adapted using Prolene 2/0 running sutures. The fixation aims to prevent any intestinal structures to herniate onto the mesh. Afterwards, the abdominal wall is closed as described in the control group.
Investigations
Preoperative investigations: Standardized interview with the assessment of abdominal pain using the visual analog scale (0-10). Clinical exam investigating the impairment of mobility of the trunk (Inclination, reclination, rotation) all measured in degrees.
Postoperative investigations: Regular clinical investigation at discharge by the treating surgeon All patients receive a follow-up phone call 30 days after the operation to assess incidence of surgical site infections and other complications. Follow up controls for the study will be performed after 6 weeks, 12 months and 36 months. Incisional hernia will be diagnosed by clinical examinations and in doubt by computed tomography. Postoperative clinical investigations are free of charge for the patient. Additional investigations that may be required for the regular treatment of the patient such as computed tomography will be billed to the health insurance. Postoperative abdominal pain is assessed for seven days during the hospitalization using visual analog scale (0-10). At follow up patients undergo a standardized interview with the assessment of abdominal pain using the visual analog scale (0-10). At follow up a clinical exam is performed investigating the impairment of morbidity of the trunk (Inclination, reclination, rotation) all measured in degrees.
Direct in-hospital costs: For the determination of costs only in-hospital costs will be included in the analysis. Only hospitalizations that directly relate to complications or reoperations of the incisional hernia will be included in the study. O p e r a t e u r :
Operation:
Dauer Operation (Gesamtdauer in min):
Dauer Implantation Netz (min):
Intraoperative Komplikationen
Bemerkungen:
Art Behandlung
Blutung Darmverletzung Netzkomplikationen
